Catheter Precision, Inc. — Director's Dealing 2026

Feb 18, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Catheter Precision, Inc. (VTAK)
CIK: 0001716621
Period of Report: 2026-02-12

Reporting Person: JENKINS DAVID A (Director, Chairman of the Board and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-12	Series J Preferred Stock	$1.56	J	2491.293	Acquired		Common Stock (1596983)	Direct
2026-02-12	Series J Preferred Stock	$1.56	J	6998.1950	Acquired		Common Stock (4486022)	Indirect

Footnotes

F1: Series J Exchange Agreement entered into with the Company to cancel accrued royalty amount and terminate royalty right in exchange for Series J Preferred Stock, as more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2026 (the "Form 8-K").

F2: Series J Preferred Stock is not exercisable until stockholder approval is received, as more fully described in the Form 8-K.

F3: Series J Preferred Stock has no expiration date.

F4: The consideration and price paid for the Series J Preferred Stock is more fully described in the Form 8-K.

F5: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP.